Hspa1L Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Heat Shock Protein Family A (Hsp70) Member 1-Like is encoded by the HSPA1L gene located on chromosome 1p36.33. This gene encodes a protein belonging to the Hsp70 family of molecular chaperones, which are highly conserved proteins involved in protein folding, refolding, assembly, and degradation. HSPA1L is a testis-specific Hsp70-like protein with specialized functions in spermatogenesis and cellular stress protection. It shares high homology with HSPA1A (Hsp70-1) and HSPA1B (Hsp70-2), the major inducible heat shock proteins. [1]
| Gene Symbol | HSPA1L |
|---|---|
| Full Name | Heat Shock Protein Family A (Hsp70) Member 1-Like |
| Chromosome | 1p36.33 |
| NCBI Gene ID | 3312 |
| OMIM | 140100 |
| Ensembl ID | ENSG00000213401 |
| UniProt ID | P0DMV8 |
| Protein Length | 641 amino acids |
| Molecular Weight | 70.2 kDa |
HSPA1L contains the canonical Hsp70 domain architecture:
The ATPase domain contains the Walker A (P-loop) motif for ATP binding and Walker B motif for ATP hydrolysis. The EEVD motif at the C-terminus is a characteristic feature of cytosolic Hsp70 proteins, involved in co-chaperone interactions.
HSPA1L performs the following molecular functions:
HSPA1L exhibits a unique expression profile:
| Disease | Mechanism | Evidence |
|---|---|---|
| Male infertility | Essential for spermatogenesis | Knockout mouse studies |
| Autoimmune diseases | Aberrant expression triggers immune response | Patient autoantibody studies |
| Neurodegeneration | Impaired protein quality control | Association with AD/PD |
| Cancer | Altered stress response in tumor cells | Differential expression |
HSPA1L contributes to neurodegeneration through:
HSPA1L as a therapeutic target:
HSPA1L knockout mice exhibit:
The study of Hspa1L Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.